In 2011, The New York University School of Medicine established a new, state-of-the-art Neuroscience Institute, with special thanks to a $100M founding gift from the Druckenmiller Foundation.

The Institute leverages NYU’s excellence in both basic science and clinical medicine. By developing strategic links and fostering innovative collaborations, we are addressing some of society’s most challenging health care issues, from Alzheimer’s disease and epilepsy to multiple sclerosis, psychiatric disorders, and malignant brain tumors.